Does RANOLAZINE Cause Product substitution issue? 17 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Product substitution issue have been filed in association with RANOLAZINE (Ranolazine). This represents 0.2% of all adverse event reports for RANOLAZINE.
17
Reports of Product substitution issue with RANOLAZINE
0.2%
of all RANOLAZINE reports
0
Deaths
0
Hospitalizations
How Dangerous Is Product substitution issue From RANOLAZINE?
Of the 17 reports.
Is Product substitution issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RANOLAZINE. However, 17 reports have been filed with the FAERS database.
What Other Side Effects Does RANOLAZINE Cause?
Death (692)
Myocardial infarction (610)
Stent placement (593)
Chest pain (592)
Angina pectoris (583)
Dizziness (517)
Dyspnoea (348)
Cerebrovascular accident (334)
Fall (299)
Off label use (270)
What Other Drugs Cause Product substitution issue?
AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (2,832)
BUPROPION (1,578)
METHYLPHENIDATE (1,408)
CLONAZEPAM (1,288)
LAMOTRIGINE (979)
ALBUTEROL (864)
LEVOTHYROXINE (803)
DULOXETINE (766)
ESTRADIOL (692)
SERTRALINE (636)
Which RANOLAZINE Alternatives Have Lower Product substitution issue Risk?
RANOLAZINE vs RAPAMUNE
RANOLAZINE vs RASAGILINE
RANOLAZINE vs RASBURICASE
RANOLAZINE vs RAVULIZUMAB
RANOLAZINE vs RAVULIZUMAB-CWVZ